Abstract
When a burn patient arrives to the emergency room is a crucial time point. Very important decisions must be taken based on the assessment made in the emergency room. In this chapter, we describe the initial assessment and the consequences resulting from it (e.g., surgical burn wound management, location specific treatment).
Access provided by Autonomous University of Puebla. Download chapter PDF
Similar content being viewed by others
Keyword
1 Introduction
Burn care has markedly improved over the last decades. The probability to survive extent burn injuries is higher than ever before (Fig. 1). Thus, the main goal of current burn care extends beyond the preservation of life to re-integration of burn victims into their families, communities, work, and daily life. But before this can be achieved, the patient has to survive. Beside intensive care treatment, evaluation of sepsis using the current sepsis-3 definition/criteria, adequate analgesia, enough resuscitation, and prevention of infections the surgical intervention is a central aspect of the whole treatment in acute burns. This chapter describes the surgical part on how to handle acute burn injuries.
2 Burn Wound Evaluation
One of the major challenges any burn surgeon must face is the decision on the nature of the further treatment of his or her burn patient (i.e., conservative versus surgical treatment). This decision depends on factors like localization, depth, and extent of the burn injury. However, current literature agrees that accurate burn wound evaluation is crucial for the further treatment. Today, there are many tools which can assist when it comes to the evaluation of burn depth and burn extent. Just to mention the Laser Speckle and Laser Doppler for burn depth assessment or different software tools like Burn Case 3D or the Rapid Burn Assessor mobile app for objective burn size evaluation.
3 Escharotomy/Fasciotomy
In burn surgery, the indication for an immediate surgical intervention occurs in the presence of circumferential deep burns affecting the upper/lower extremities or the chest wall. While in the extremities the development of a compartment syndrome is the main problem, in the chest wall ventilation problems can occur due to chest wall restriction. In order to prevent compartment syndrome or ventilation problems, an escharotomy should be performed. In high-voltage burn injuries, a fasciotomy of the different muscle compartments of the upper/lower extremity should be considered too.
4 Surgical Burn Wound Management
Once the decision has been taken whether an escharotomy/fasciotomy is necessary, the next steps for the surgical treatment must be planned. The main goal of the surgical treatment is the replacement of the destroyed necrotic tissue. Superficial dermal burns will heal without operation within 2–3 weeks, but deep dermal and full-thickness burn will require operation. It is widely accepted that if skin does not regenerate within 3 weeks, morbidity and scarring will be severe. Further, it has become apparent that early excision is better than late excision because after 7 days the incidence of sepsis and graft failure increases. So, the trend regarding the treatment of deep dermal and full-thickness burns is going towards very early excision and grafting within 72 h after injury in order to reduce the risk of infection, decrease scar formation, shorten hospital stay, and thereby reduce total costs.
The excision of the necrotic tissue should be performed whenever the patient is hemodynamically stable. The operation should never be carried out if the patient is unstable and the risk of mortality is increased. In that case, the operation should be suspended until the patient is sufficiently stable. In patients associated with additional risk factors such as inhalation injury, patients of high age, or patients with cardiac problems, the surgical treatment differs and the decision when and how much to excise should be evaluated individually from case to case.
Sequential layered tangential excision to viable bleeding points, even to fat, while minimizing the loss of viable tissue, is the generally accepted technique. Excision of burn wounds to the fascia is reserved for large and deep burns where the risks of massive blood loss and the possibility of skin slough from less vascularized grafts on fat may lead to higher mortality. Enzymatic debridement with bromelain-based agents (e.g., Nexobrid®) is an alternative method to debride smaller deep dermal and non-life-threatening burns. The advantage is that it selectively removes the eschar without damaging the vital dermis.
After tangential excision of deep dermal burn injuries, the resulting defects can be covered with autologous or allogeneic skin grafts, xenografts, keratinocytes, or by use of synthetic materials like Suprathel ® (Fig. 2). In case of full-thickness burns, we dominantly use autografts to cover the wounds if there are enough available donor sites. In large burns, we normally use expanded autografts (mesh or Meek). Expansion rates of graft to wound area cover ranges from 1:1 to 1:9. Expansion rates higher than 1:3 heal in a suboptimal manner leading to contractures and unstable scars. Therefore, we like to combine these large meshed autografts in combination with allografts (Fig. 3) or keratinocytes (sandwich technique), or we will use the Meek technique (Fig. 4). In functional important regions like hands and over joints, a combined reconstruction of skin by use of a dermal matrix (Integra®, Matriderm®) and split-thickness skin graft seems to be superior to skin grafts alone (Fig. 5).
Donor sites for autografts in smaller burns, less than 40% total body surface area are seldom a problem unless the patient has a higher risk for surgical complication resulting from age, cardiopulmonary status, or coagulopathy. In patients with very extensive burns >60 total body surface area, the scarcity of harvesting areas for autologous skin grafts is one of the main problems. Therefore, we use cadaver skin (allografts) or xenografts (Fig. 6) as a temporary transplant and cover. These temporary transplants decrease the size of open wound until autografts become available as the partial-thickness burn area is healed or previously harvested donor sites heal.
This temporary covering helps to:
-
Control wound infection.
-
Prevent wound contracture.
-
Relieve pain.
Sometimes, since burn wounds are often a mosaic of different burn depths, different techniques are combined in order to optimize burn wound closure regarding healing time and skin quality (Fig. 7).
5 Location-Specific Treatment
5.1 Face
Deep dermal burns will be debrided and covered with keratinocytes or by silver-containing dressings like Acticoat Flex®. Full-thickness burns will be excised and grafted with unmeshed skin grafts according to aesthetic units of the face.
5.2 Hands
Deep dermal burns will be debrided and covered with keratinocytes, unmeshed skin grafts, or synthetic materials like Suprathel®. Full-thickness burns will be excised and grafted with unmeshed skin grafts, sometimes in combination with dermal substitutes.
6 Treatment Standards in Burns Larger than Sixty Percent Total Body Surface Area
Body regions can be organized according to the probability of skin take rate, functional importance, and ultimately determined for surgical priority (Figs. 8 and 9). The aim of the surgical approach is to remove the necrotic tissue within 9 days after injury; in large burns, the dorsal aspects of the lower extremities, dorsum, gluteal and dorsal femoral regions can be preferably preconditioned in a fluidized microsphere beads-bed, and the final debridement is normally not performed before days 10–14 after injury. Excision and grafting sessions can be organized in a timeline scheme described in Fig. 9:
-
In young and clinically stable adult burn patients, we aimed to remove necrotic tissue and provide cover for full-thickness burns in two operative sessions within the first 14 days after injury.
-
Individuals aged 65 years and above usually required more than two operative sessions within the first 14 days because the area operated on per session had to be restrained and adapted to the patient’ general condition.
Whenever possible, unmeshed split-thickness skin grafts (STSG) are used for face and hands; all other areas are covered with either Meek grafts (expansion ratio 1:6 or 1:9) or, if respective donor sites enough, with mesh grafts using an expansion ratio of 1:1.5 or 1:3. Expansion ratios exceeding 1:3 to achieve sufficient coverage for full-thickness burns are regarded as indication for using the Meek technique (1:6 or 1:9).
7 Temporary Coverage
If harvested STSG did not suffice for coverage of full-thickness areas (i.e., third degree), we prefer to use allogeneic STSG as a temporary alternative. However, if allogeneic skin is not available, we use xenografts or a synthetic material (e.g., Epigard®) to temporarily cover debrided full-thickness areas.
Further, allograft is also used for protection of widely meshed autografts (>3:1 mesh) during healing. The allograft is applied over the meshed autograft in sandwich technique (Fig. 3). Surgical priority is given to areas of functional and aesthetic importance and superior take rate. Body regions with inferior take rate are normally preconditioned.
8 Fluidized Microsphere Beads-Bed
Fluidized microsphere beads-beds are good method for wound preconditioning but also for postoperative wound care. It removes moisture in order to keep the burn wounds dry and to permit maintenance of constant temperature levels in areas in direct contact with the bed’s superficial fabric. Only thin sterile covers are employed to shield dorsal burned areas while in these beds, and no extra ointments are applied. For wound coverage of freshly operated areas, we prefer to use fatty gauzes and dry sterile compresses. Patients with arising difficulties in respiratory management or temperature control while in fluidized microsphere beads-beds are temporarily transferred to standard intensive care beds.
9 Negative-Pressure Wound Therapy (Vacuum-Assisted Closure)
Negative-pressure wound therapy or vacuum-assisted closure (VAC®) can be used in the local therapy of STSG receiver regions of inferior take and allowed for early mobilization in functionally important zones.
9.1 Early Mobilization
Early individual physiotherapy and ergotherapeutic splinting accomplishes the therapeutic strategy.
10 Nutrition and Anabolic Agents
Catabolism as a response to thermal trauma can only be modulated, not completely reversed. The burn wound consumes large quantities of energy during the healing process due to the large population of inflammatory cells and the production of collagen and matrix by fibroblasts. Therefore, adequate nutrition is of utmost importance for burn wound healing.
Suggested Readings
Sevitt S (1949) Local blood-flow changes in experimental burns. J Pathol Bacteriol 61:427–442
Jackson DM (1953) The diagnosis of the depth of burning. Br J Surg 40:588–596
Muir I, Barclay T, Settle J (1962) Burns and their treatment. Lloyd-Luke, London
Arturson G, Mellander S (1964) Acute changes in capillary filtration and diffusion in experimental burn injury. Acta Physiol Scand 62:457–463
Snyder WH, Bowles BM, MacMillan BG (1970) The use of expansion meshed grafts in the acute and reconstructive management of thermal injury: a clinical evaluation. J Trauma 10:740–750
Burleson R, Eiseman B (1973) Effect of skin dressings and topical antibiotics on healing of partial thickness skin wounds in rats. Surg Gynecol Obstet 136:958–960
Zawacki BE (1974) The natural history of reversible burn injury. Surg Gynecol Obstet 139:867–872
Zawacki BE (1974) The natural history of reversible burn injury. Surg Gynecol Obs 139:867–872
Godina M, Derganc M, Burns AB (1977) The reliability of clinical assessment of the depth of burns. Elsevier
Herndon DN, Wilmore DW, Mason AD, Pruitt BA (1978) Increases in postburn hypermetabolism caused by application of topical ointments. Surg Forum 29:49–51
Nozaki M, Guest MM, Bond TP, Larson DL (1980) Permeability of blood vessels after thermal injury. Burns 6:213–221
Robson MC, DelBeccaro EJ, Heggers JP, Loy GL (1980) Increasing dermal perfusion after burning by decreasing thromboxane production. J Trauma 20:722–725
Engrav LH, Heimbach DM, Reus JL, Harnar TJ, Marvin JA (1983) Early excision and grafting vs. nonoperative treatment of burns of indeterminant depth: a randomized prospective study. J Trauma 23:1001–1004
Ehrlich HP (1984) Promotion of vascular patency in dermal burns with Ibuprofen. Am J Med 77:107–113
Hambrecht GS, Hilton JG (1984) The effects of catalase, indomethacin and FPL 55712 on vascular permeability in the hamster cheek pouch following scald injury. Prostaglandins Leukot Med 14:297–304
Boswick J. (1987) The art and science of burn care
Herndon DN, Curreri PW, Abston S, Rutan TC, Barrow RE (1987) Treatment of burns. Curr Probl Surg 24:341–397
Melikian V, Laverson S, Zawacki B (1987) Oxygen-derived free radical inhibition in the healing of experimental zone-of-stasis burns. J Trauma 27:151–154
Lund T, Wiig H, Reed RK (1988) Acute postburn edema: role of strongly negative interstitial fluid pressure. Am J Physiol 255:H1069–H1074
Spurr ED, Shakespeare PG (1990) Incidence of hypertrophic scarring in burn-injured children. Burns 16:179–181
Heimbach D, Engrav L, Grube B, Marvin J (1992) Burn depth: a review. World J Surg 16:10–15
Still JM, Law EJ, Belcher K, Thiruvaiyarv D (1996) Decreasing length of hospital stay by early excision and grafting of burns. South Med J 89:578–582
Cetinkale O, Demir M, Sayman HB, Ayan F, Onsel C (1997) Effects of allopurinol, ibuprofen and cyclosporin A on local microcirculatory disturbances due to burn injuries. Burns 23:43–49
Kuroda T, Harada T, Tsutsumi H, Kobayashi M (1997) Hypernatremia deepens the demarcating borderline of leukocytic infiltration in the burn wound. Burns 23:432–437
Morykwas MJ, David LR, Schneider AM, Whang C, Jennings DA, Canty C et al (1999) Use of subatmospheric pressure to prevent progression of partial-thickness burns in a swine model. J Burn Care Rehabil 20:15–21
Watts AMI, Tyler MPH, Perry ME, Roberts AHN, McGrouther DA (2001) Burn depth and its histological measurement. Burns 27:154–160
Tan Q, Lin Z, Ma W, Chen H, Wang L, Ning G et al (2002) Failure of Ibuprofen to prevent progressive dermal ischemia after burning in guinea pigs. Burns 28:443–448
Kamolz L, Andel H, Haslik W, Donner A, Burns WW (2003) Indocyanine green video angiographies help to identify burns requiring operation. Elsevier
Kamolz L-P, Andel H, Haslik W, Winter W, Meissl G, Frey M (2004) Use of subatmospheric pressure therapy to prevent burn wound progression in human: first experiences. Burns 30:253–258
Haslik W, Kamolz L-P, Nathschläger G, Andel H, Meissl G, Frey M (2007) First experiences with the collagen-elastin matrix Matriderm as a dermal substitute in severe burn injuries of the hand. Burns 33:364–368
Kamolz L-P, Kitzinger HB, Karle B, Frey M (2009) The treatment of hand burns. Burns 35:327–337
Lumenta DB, Kamolz L-P, Frey M (2009) Adult burn patients with more than 60% TBSA involved-Meek and other techniques to overcome restricted skin harvest availability—the Viennese Concept. J Burn Care Res 30:231–242
Haslik W, Kamolz L-P, Lumenta DB, Hladik M, Beck H, Frey M (2010) The treatment of deep dermal hand burns: how do we achieve better results? Burns 36:329–334
Haslik W, Kamolz L-P, Manna F, Hladik M, Rath T, Frey M (2010) Management of full-thickness skin defects in the hand and wrist region: first long-term experiences with the dermal matrix Matriderm. J Plast Reconstr Aesthet Surg 63:360–364
Lumenta DB, Kamolz L-P, Keck M, Frey M (2011) Comparison of meshed versus MEEK micrografted skin expansion rate: claimed, achieved, and polled results. Plast Reconstr Surg 128:40e–41e
Keck M, Selig HF, Lumenta DB, Kamolz LP, Mittlböck M, Frey M (2012) The use of Suprathel(®) in deep dermal burns: first results of a prospective study. Burns 38:388–395
Selig HF, Lumenta DB, Giretzlehner M, Jeschke MG, Upton D, Kamolz LP (2012) The properties of an “ideal” burn wound dressing—what do we need in daily clinical practice? Results of a worldwide online survey among burn care specialists. Burns 38:960–966
Kamolz LP, Lumenta DB, Parvizi D, Dirnberger J, Owen R, Höller J et al (2014) Smartphones and burn size estimation: “Rapid Burn Assessor”. Ann Burns Fire Disasters 27:101–104
Rowan MP, Cancio LC, Elster EA, Burmeister DM, Rose LF, Natesan S et al (2015) Burn wound healing and treatment: review and advancements. Crit Care 19:243
Parvizi D, Giretzlehner M, Wurzer P, Klein LD, Shoham Y, Bohanon FJ et al (2016) BurnCase 3D software validation study: burn size measurement accuracy and inter-rater reliability. Burns 42:329–335
Hirche C, Citterio A, Hoeksema H, Koller J, Lehner M, Martinez JR et al (2017) Eschar removal by bromelain based enzymatic debridement (Nexobrid®) in burns: an European consensus. Burns 43:1640–1653
Elmasry M, Mirdell R, Tesselaar E, Farnebo S, Sjöberg F, Steinvall I (2019) Laser speckle contrast imaging in children with scalds: its influence on timing of intervention, duration of healing and care, and costs. Burns 45:798–804
Jaspers MEH, van Haasterecht L, van Zuijlen PPM, Mokkink LB (2019) A systematic review on the quality of measurement techniques for the assessment of burn wound depth or healing potential. Burns 45:261–281
Zhang L, Hughes PG (2019) Escharotomy
Meza-Escobar LE, Rehou S, Jeschke MG (2020) Surg Infect (Larchmt). Sepsis Definitions in Burns. https://doi.org/10.1089/sur.2020.297. Online ahead of print. PMID: 33026946
Yan J, Hill WF, Rehou S, Pinto R, Shahrokhi S, Jeschke MG (2018). Sepsis criteria versus clinical diagnosis of sepsis in burn patients: A validation of current sepsis scores. Surgery 164(6):1241–1245. https://doi.org/10.1016/j.surg.2018.05.053. Epub 2018 Jul 23. PMID: 30049483 Free PMC article
Author information
Authors and Affiliations
Corresponding author
Editor information
Editors and Affiliations
Rights and permissions
Copyright information
© 2021 Springer Nature Switzerland AG
About this chapter
Cite this chapter
Tuca, AC., Winter, R., Kamolz, LP. (2021). Acute Burn Surgery. In: Jeschke, M.G., Kamolz, LP., Shahrokhi, S. (eds) Burn Care and Treatment. Springer, Cham. https://doi.org/10.1007/978-3-030-39193-5_3
Download citation
DOI: https://doi.org/10.1007/978-3-030-39193-5_3
Published:
Publisher Name: Springer, Cham
Print ISBN: 978-3-030-39192-8
Online ISBN: 978-3-030-39193-5
eBook Packages: MedicineMedicine (R0)